Concepedia

Publication | Open Access

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

365

Citations

22

References

2014

Year

References

YearCitations

Page 1